DBV Technologies | DBVT - Devedores Comerciais





Devedores Comerciais Alterar Data
Acadia Pharmaceuticals USD 148.38M 153K 2026-03
Alnylam Pharmaceuticals USD 883.96M 106.39M 2026-03
Amarin USD 126.83M 477K 2025-12
BioCryst Pharmaceuticals USD 106.82M 15.49M 2025-12
BioMarin Pharmaceutical USD 903.91M 4.3M 2026-03
DBV Technologies USD 15.97M 279K 2025-09
Esperion Therapeutics USD 140.19M 21.21M 2025-12
Halozyme Therapeutics USD 457.99M 16.72M 2026-03
Incyte USD 1.05B 27.09M 2026-03
Insmed USD 178.55M 37.7M 2026-03
Ionis Pharmaceuticals USD 74M 8M 2026-03
Neurocrine Biosciences USD 768.1M 81.3M 2026-03
PTC Therapeutics USD 181.62M 21.45M 2025-12
Sarepta Therapeutics USD 547.91M 149.68M 2026-03
Ultragenyx Pharmaceutical USD 60M 98M 2026-03
United Therapeutics USD 312M 38.2M 2026-03